Approximately 405,000 ventral hernia repairs are performed annually in the US and the recurrence rate is approximately 20% as a result of failure at the suture, mesh, tissue anchor interface. To overcome this failure mode, we invented a knitted polypropylene hernia mesh with suture-like integrated mesh extensions that are 15X the surface area of #0 suture and anchor the mesh akin to suture. Physicomechanical benchtop and sterility testing was completed to FDA standards and the test mesh was implanted in swine to determine anchoring strength compared to a control reference mesh.
METHODS:
The polypropylene T-line mesh was fabricated with extensions .5-1cm wide, 50cm long, and spaced 2cm apart. Mesh thickness was 0.5mm, average pore size 2.8mm and density was 90g/m2. Tongue tear resistance, ball burst, suture retention, tensile strength-strain, and extension tensile strength testing were performed (n=10 per each test) and compared to a control reference polypropylene mesh. Meshes were sterilized by ethylene oxide, gas, and gamma sterilization (n=10 per each mesh) and physicomechanical testing performed post sterilization. The test mesh and predicate mesh were implanted in a swine ventral hernia model (n=4) and harvested 1 day post-operatively for mechanical testing to model mesh/suture/tissue failure in the peri-operative period when most meshes are thought to be at greatest risk of failure.
RESULTS:
In vitro mechanical performance demonstrated that the T-line mesh outperformed the control predicate mesh in all tested parameters. Mechanical analysis of swine specimens demonstrated the mean peak load to failure for T-line mesh was 134.5 N (SD +/-54.5 N), compared to 49.0 N for the control reference mesh (SD +/-13.4 N). The T-line mesh failure always occurred by the extensions tearing through tissue. The control mesh failed 60% of the time by one suture tearing through tissue and the second suture tearing through mesh, and the remaining 40% of failures was from both sutures tearing through mesh. The T-line mesh significantly outperformed control mesh and averaged 275% stronger on peak load performance.
CONCLUSION:
The T-line mesh is a polypropylene, macroporous, heavyweight mesh that meets all FDA standards and outperforms a control predicate mesh in all mechanical performance tests. The T-line mesh can be sterilized by ethylene oxide, gas, or gamma sterilization without undue effects. The T-line mesh is 275% stronger than a control reference mesh in the immediate post-operative period when anchor strength is needed most. Future efforts are directed towards manufacturing the T-line mesh mesh with needles swaged onto the extensions, determining packaging conformations, and completing systemic and local tissue toxicity testing per FDA standards for 510(k) clearance. The T-line mesh has the potential to dramatically reduce hernia occurrence and recurrence.
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nerve conduits would improve nerve regeneration and rodent extremity function by decreasing scar deposition at nerve co-aptation sites.
METHODS:
We utilized a novel, rat forelimb chronic denervation (CD) model to assess the effects of PCL conduits on: a) improving nerve regeneration; and b) improving upper extremity function. Three groups of rats were examined: (1) Group-1 (n = 5) underwent 8 weeks of median nerve CD injury followed by repair with no conduit; (2) Group-2 (experimental, n = 5) underwent 8 weeks of median nerve CD followed by repair and PCL nerve conduit wrapping of the nerve co-aptation site; (3) Group-3 animals (n = 5) were naïve controls. All animals underwent nerve conduction studies on weeks 12 post-repair. All animals also underwent weekly muscle functional testing. At weeks 14 post-repair, the median nerve and flexor muscles were harvested for nerve histomorphometry and muscle weight. To enable the assessment of scarring at the nerve repair site, nerve samples were stained for collagen using direct red 80 sirius red stain. A student t-test was used to evaluate for statistical significance.
RESULTS:
Histomorphometric analysis of regenerating nerve fibers in the median nerve demonstrated relatively robust axonal regeneration in Group 2, with higher total axon count, myelin thickness, axon diameter when compared to the Group 1. The difference in total axon count between Group 2 and 1 was statistically significant (Group 2 = 1769 ± 672 axons, Group 1 = 1072 ± 123.80 axons, p = 0.0468). Furthermore, the difference in flexor muscle mass weight between the group 2 and group 1 was statistically significant (Group 2 = 0.629 ± 0.054, Group 1 = 0.511 ± 0.07, p < 0.05). With regard to functional recovery, at 14 weeks post-repair, Group 2 had regained 34.9 % of naïve baseline hand grip strength. In comparison, Group 1 regained only 25.4% of baseline hand grip strength. Between group 2 and 1, the difference in grip strength was statistically significant (Group 2 = 1.67 ± 0.04, Group 1 = 0.97 ± 0.39, p = 0.036). Sirius red staining revealed less collagen deposition at the nerve co-aptation site of Group 2 animals when compared to group 1 animals (p < 0.05).
CONCLUSION:
Biodegradable, PCL nanofiber nerve conduits can improve nerve regeneration and subsequent physiological extremity function in the setting of delayed nerve repair by decreasing the scar burden at nerve co-aptation sites. 
